BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 14670641)

  • 1. Classification and pharmacology of progestins.
    Schindler AE; Campagnoli C; Druckmann R; Huber J; Pasqualini JR; Schweppe KW; Thijssen JH
    Maturitas; 2003 Dec; 46 Suppl 1():S7-S16. PubMed ID: 14670641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification and pharmacology of progestins.
    Schindler AE; Campagnoli C; Druckmann R; Huber J; Pasqualini JR; Schweppe KW; Thijssen JH
    Maturitas; 2008; 61(1-2):171-80. PubMed ID: 19434889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of newer progestogens.
    Kuhl H
    Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of progestins.
    Sitruk-Ware R
    Maturitas; 2008; 61(1-2):151-7. PubMed ID: 19434887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of progestins.
    Sitruk-Ware R
    Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay.
    McRobb L; Handelsman DJ; Kazlauskas R; Wilkinson S; McLeod MD; Heather AK
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):39-47. PubMed ID: 18395441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile of contraceptive progestins.
    Benagiano G; Primiero FM; Farris M
    Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):182-93. PubMed ID: 15697108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New progestagens for contraceptive use.
    Sitruk-Ware R
    Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
    Cartwright M; Toit RL; Africander D
    Biochem Biophys Res Commun; 2023 Jan; 639():70-76. PubMed ID: 36470074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3.
    Beranič N; Gobec S; Rižner TL
    Chem Biol Interact; 2011 May; 191(1-3):227-33. PubMed ID: 21182831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
    Schoonen WG; Deckers G; de Gooijer ME; de Ries R; Mathijssen-Mommers G; Hamersma H; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
    Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
    Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of progestogens and the risk of intracranial meningioma: national case-control study.
    Roland N; Neumann A; Hoisnard L; Duranteau L; Froelich S; Zureik M; Weill A
    BMJ; 2024 Mar; 384():e078078. PubMed ID: 38537944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
    Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
    Sitruk-Ware R
    Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
    Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
    Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high resolution LC-MS targeted method for the concomitant analysis of 11 contraceptive progestins and 4 steroids.
    Laszlo CF; Paz Montoya J; Shamseddin M; De Martino F; Beguin A; Nellen R; Bruce SJ; Moniatte M; Henry H; Brisken C
    J Pharm Biomed Anal; 2019 Oct; 175():112756. PubMed ID: 31387028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor.
    Herkert O; Kuhl H; Sandow J; Busse R; Schini-Kerth VB
    Circulation; 2001 Dec; 104(23):2826-31. PubMed ID: 11733402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.